(2020). Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Chicago Style (17th ed.) CitationConcerns About Pharmacokinetic (PK) and Pharmacokinetic-pharmacodynamic (PK-PD) Studies in the New Therapeutic Area of COVID-19 Infection. 2020.
MLA (8th ed.) CitationConcerns About Pharmacokinetic (PK) and Pharmacokinetic-pharmacodynamic (PK-PD) Studies in the New Therapeutic Area of COVID-19 Infection. 2020.
Warning: These citations may not always be 100% accurate.